CTLT - Catalent Inc Stock Price, Fair Value and News

55.95USD-0.08 (-0.14%)Market Closed

Market Summary

USD55.95-0.08

Market Closed

-0.14%

CTLT Alerts

Big jump in Earnings (Y/Y)

CTLT Stock Price

View Fullscreen

CTLT RSI Chart

CTLT Valuation

Market Cap

10.1B

Price/Earnings (Trailing)

-9.43

Price/Sales (Trailing)

2.47

EV/EBITDA

-12.22

Price/Free Cashflow

-32.68

CTLT Price/Sales (Trailing)

CTLT Profitability

EBT Margin

-35.09%

Return on Equity

-29.16%

Return on Assets

-10.76%

Free Cashflow Yield

-3.06%

CTLT Fundamentals

CTLT Revenue

Revenue (TTM)

4.1B

Rev. Growth (Yr)

-10.88%

Rev. Growth (Qtr)

4.28%

CTLT Earnings

Earnings (TTM)

-1.1B

Earnings Growth (Yr)

100%

Earnings Growth (Qtr)

100%

Breaking Down CTLT Revenue

Last 7 days

0.5%

Last 30 days

0.5%

Last 90 days

12.9%

Trailing 12 Months

24.7%

How does CTLT drawdown profile look like?

CTLT Financial Health

Current Ratio

2.48

Debt/Equity

1.34

Debt/Cashflow

0.04

CTLT Investor Care

Shares Dilution (1Y)

0.36%

Diluted EPS (TTM)

-7.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.5B	4.3B	4.2B	4.1B
2022	4.7B	4.8B	4.8B	4.7B
2021	5.9B	4.0B	4.2B	4.5B
2020	2.9B	5.2B	5.4B	5.6B
2019	2.5B	2.5B	2.6B	2.7B
2018	2.4B	2.5B	2.5B	2.5B
2017	2.0B	2.1B	2.2B	2.3B
2016	1.8B	1.8B	1.9B	1.9B
2015	1.8B	1.8B	1.8B	1.8B
2014	1.8B	1.8B	1.8B	1.8B
2013	1.8B	1.8B	1.8B	1.8B
2012	0	1.7B	1.7B	1.7B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Catalent Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	gunther scott	sold	-21,749	56.2	-387	svp, quality & reg. affairs
Jan 25, 2024	kreuzburg christa	sold (taxes)	-26,364	50.41	-523	-
Jan 16, 2024	hatzfeld michael	acquired	-	-	7,908	chief accounting officer
Dec 08, 2023	hopson ricky	sold (taxes)	-9,518	37.18	-256	pres. clinical dev supply div
Dec 08, 2023	maselli alessandro	acquired	-	-	3,761	president & ceo
Dec 08, 2023	gennadios aristippos	acquired	-	-	1,505	group pres. pharma & consumer
Dec 08, 2023	hopson ricky	acquired	-	-	747	pres. clinical dev supply div
Dec 08, 2023	gunther scott	acquired	-	-	1,023	svp, quality & reg. affairs
Dec 08, 2023	gennadios aristippos	sold (taxes)	-13,645	37.18	-367	group pres. pharma & consumer
Dec 08, 2023	maselli alessandro	sold (taxes)	-71,534	37.18	-1,924	president & ceo

Which funds bought or sold CTLT recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-12.65	273,000	3,075,000	0.03%
Apr 23, 2024	FIFTH THIRD BANCORP	reduced	-79.33	-944,853	331,474	-%
Apr 23, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	reduced	-3.19	92,000	514,000	0.02%
Apr 23, 2024	REGIONS FINANCIAL CORP	reduced	-85.92	-1,181,030	253,855	-%
Apr 23, 2024	Hunter Perkins Capital Management, LLC	reduced	-6.93	249,000	1,725,000	0.35%
Apr 23, 2024	Global Retirement Partners, LLC	reduced	-52.66	-24,782	29,185	-%
Apr 23, 2024	Louisiana State Employees Retirement System	reduced	-3.67	102,988	592,725	0.01%
Apr 23, 2024	Livforsakringsbolaget Skandia, Omsesidigt	unchanged	-	1,148	5,641	-%
Apr 23, 2024	Venturi Wealth Management, LLC	added	20.00	1,027	3,049	-%
Apr 22, 2024	IFM Investors Pty Ltd	added	10.48	561,402	2,006,400	0.02%

Are Funds Buying or Selling CTLT?

Are funds buying CTLT calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CTLT

No. of Funds

CTLT Alerts

Big jump in Earnings (Y/Y)

Unveiling Catalent Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	6.2%	11,209,374	SC 13G/A
Feb 14, 2024	nomura holdings inc	6.4%	11,487,158	SC 13G
Feb 13, 2024	janus henderson group plc	7.3%	13,249,339	SC 13G/A
Feb 13, 2024	vanguard group inc	11.17%	20,186,499	SC 13G/A
Feb 12, 2024	veritas asset management llp	3.58%	6,467,989	SC 13G/A
Feb 09, 2024	capital world investors	10.6%	19,113,006	SC 13G/A
Jan 25, 2024	blackrock inc.	9.0%	16,175,385	SC 13G/A
Oct 10, 2023	capital world investors	10.0%	18,029,128	SC 13G/A
Feb 14, 2023	t. rowe price investment management, inc.	9.2%	16,578,946	SC 13G/A
Feb 13, 2023	capital world investors	7.7%	13,914,820	SC 13G/A

Recent SEC filings of Catalent Inc

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	DEFA14A	DEFA14A
Apr 15, 2024	DEFM14A	DEFM14A
Apr 09, 2024	S-8	Employee Benefits Plan
Apr 03, 2024	PREM14A	PREM14A
Mar 19, 2024	4	Insider Trading
Mar 15, 2024	144	Notice of Insider Sale Intent
Mar 12, 2024	144	Notice of Insider Sale Intent
Mar 01, 2024	8-K	Current Report
Feb 14, 2024	10-Q	Quarterly Report
Feb 14, 2024	SC 13G	Major Ownership Report

Peers (Alternatives to Catalent Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	360.2B	85.2B	-3.67%	-8.64%	10.25	4.23	6.46%	95.94%
MRK	321.4B	60.1B	2.46%	9.45%	880.53	5.35	1.40%	-97.49%
PFE	148.6B	46.5B	-3.80%	-34.05%	-107.04	3.19	42.59%	-114.62%
AMGN	146.6B	28.2B	-0.95%	11.90%	21.82	5.2	7.09%	2.52%
GILD	83.5B	27.1B	-7.68%	-22.69%	14.74	3.08	-0.60%	23.36%
TEVA	14.6B	15.8B	-6.26%	55.93%	-25.32	0.92	6.17%	76.47%
MID-CAP
PRGO	4.1B	4.7B	-2.65%	-15.52%	-325.34	0.89	4.58%	90.97%
ALKS	4.1B	1.7B	-11.07%	-16.83%	11.39	2.44	49.61%	324.78%
BHC	3.1B	8.8B	-10.77%	12.83%	-5.27	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-6.43%	-0.05%	14.31	3.05	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-20.35%	-21.70%	-4.05	1.92	24.65%	80.36%
TXMD	21.7M	1.3M	-17.90%	-49.19%	-2.11	16.65	-98.14%	-109.18%
ACRX	16.3M	-	-14.29%	38.83%	-0.89	0.22	2882.68%	-138.52%
AGRX	2.5M	19.6M	-32.73%	-94.43%	-0.18	0.13	80.00%	43.08%
ACOR	645.9K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

Catalent Inc News

Latest updates

Catalent Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	4.3%	1,024	982	1,055	1,037	1,149	1,022	1,287	1,273	1,217	1,025	1,188	1,053	911	846	3,094	761	721	665	726	618	623
Gross Profit	1.2%	171	169	215	180	387	258	462	423	405	324	439	366	298	249	335	239	232	178	257	199	201
S&GA Expenses	22.0%	250	205	217	190	226	196	226	207	228	183	184	173	165	165	157	136	141	143	143	130	123
EBITDA Margin	-36.4%	-0.30*	-0.22*	-0.02*	0.06*	0.16*	0.16*	0.17*	0.18*	0.22*	0.23*	0.22*	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-13.8%	-66.00	-58.00	-56.00	-51.00	-47.00	-32.00	-32.00	-33.00	-32.00	-26.00	-31.50	-27.00	-26.00	-26.00	-20.40	-34.40	-34.90	-36.30	-31.00	-26.40	-25.50
Income Taxes	163.2%	24.00	-38.00	-67.00	-55.00	33.00	3.00	17.00	35.00	18.00	10.00	39.00	85.00	21.00	-15.00	24.00	9.00	13.00	-6.90	9.00	11.00	2.00
Earnings Before Taxes	77.2%	-182	-797	-177	-282	114	3.00	185	176	115	103	222	317	109	67.00	179	30.00	59.00	-6.80	80.00	43.00	51.00
EBT Margin	-29.8%	-0.35*	-0.27*	-0.08*	0.00*	0.10*	0.10*	0.12*	0.13*	0.17*	0.18*	0.18*	-	-	-	-	-	-	-	-	-	-
Net Income	72.9%	-206	-759	-110	-227	81.00	-	168	141	97.00	93.00	183	232	88.00	82.00	154	21.00	46.00	0.00	71.00	32.00	49.00
Net Income Margin	-32.2%	-0.32*	-0.24*	-0.06*	0.00*	0.08*	0.08*	0.10*	0.11*	0.13*	0.14*	0.15*	-	-	-	-	-	-	-	-	-	-
Free Cashflow	111.7%	18.00	-154	58.00	-202	46.00	-241	-166	-10.00	-54.00	9.00	-55.00	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q2	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	5.2%	10,508	9,988	10,023	10,777	10,830	11,148	10,206	10,508	10,322	10,203	10,183	9,112	8,769	8,198	7,984	7,777	7,080	6,195	6,120	6,184	4,493
Current Assets	13.5%	2,917	2,570	2,614	2,692	2,738	2,919	2,699	2,917	3,025	2,974	3,931	2,918	2,775	2,519	2,356	2,293	1,746	1,301	1,267	1,396	1,144
Cash Equivalents	-100.0%	-	229	209	280	252	442	281	449	786	849	1,969	896	988	833	1,007	953	608	189	243	345	228
Inventory	-100.0%	-	775	796	777	744	818	732	702	676	688	622	563	528	461	384	324	297	250	251	257	247
Net PPE	-100.0%	-	3,777	3,723	3,682	3,671	3,579	3,167	3,127	2,820	2,727	2,581	2,524	2,359	2,130	2,036	1,901	1,770	1,618	1,561	1,537	1,302
Goodwill	-100.0%	-	2,351	2,316	3,039	3,023	3,215	2,929	3,006	3,012	3,026	2,531	2,519	2,515	2,462	2,490	2,471	2,449	2,208	2,196	2,221	1,409
Liabilities	-9.0%	5,733	6,301	6,182	6,166	6,127	6,256	5,526	5,733	5,690	5,722	5,803	4,838	4,697	4,384	4,306	4,271	4,285	3,873	3,864	3,896	3,783
Current Liabilities	6.0%	1,098	1,036	1,534	1,530	1,487	1,552	969	1,098	1,046	1,045	1,096	1,196	1,139	1,024	920	893	917	658	616	671	525
Long Term Debt	-100.0%	-	4,959	4,322	4,313	4,261	4,221	4,098	4,171	4,157	4,191	4,225	3,166	3,150	2,984	2,985	2,945	2,927	2,825	2,859	2,883	2,116
Shareholder's Equity	29.5%	4,775	3,687	3,841	4,611	4,892	4,912	4,700	4,775	4,632	4,481	4,021	3,915	3,713	3,456	3,072	2,899	2,188	1,716	1,649	1,682	1,621
Retained Earnings	173.7%	518	-703	-497	262	372	619	518	518	350	209	114	25.00	-150	-377	-460	-535	-681	-694	-731	-723	-790
Additional Paid-In Capital	-100.0%	-	4,742	4,724	4,701	4,697	4,686	4,674	4,649	4,630	4,615	4,234	4,205	4,186	4,161	3,901	3,818	3,261	2,759	2,755	2,757	2,739
Accumulated Depreciation	-100.0%	-	1,756	1,647	1,596	1,540	1,465	1,358	1,347	1,308	1,215	1,215	1,179	-	-	-	-	-	-	-	-	-
Shares Outstanding	-100.0%	-	180	180	179	180	180	180	179	179	171	171	171	170	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	-	-	-	-	7,900	-	-	-	17,710	-	-	-	8,200	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	260.0%	112,000	-70,000	196,000	-64,000	214,000	-92,000	69,000	138,000	69,000	163,000	134,000	75,000	74,000	150,000	172,400	121,700	120,700	25,200	88,200	75,300	43,300
Share Based Compensation	-15.8%	16,000	19,000	-	6,000	10,000	19,000	12,000	10,000	11,000	21,000	13,000	-	-	-	-	-	-	-	-	-	-
Cashflow From Investing	-13.1%	-95,000	-84,000	-121,000	-110,000	-608,000	-116,000	-394,000	-191,000	-1,132,000	-167,000	-213,000	-82,000	-203,000	-151,000	-162,200	-465,600	-114,300	-84,900	-1,252,300	-48,900	-43,000
Cashflow From Financing	-114.3%	-14,000	98,000	-51,000	-25,000	523,000	74,000	1,000	-3,000	-49,000	1,082,000	-17,000	166,000	-57,000	50,000	331,300	772,500	-66,000	-35,800	1,283,500	-8,700	-55,000
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,800	83,600	-	494,200	-	-	-	-200	-

CTLT Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Income Statement [Abstract]

Net revenue

$ 1,024.0

$ 1,149.0

$ 2,006.0

$ 2,171.0

Cost of sales

853.0

762.0

1,666.0

1,526.0

Gross margin

171.0

387.0

340.0

645.0

Selling, general, and administrative expenses

250.0

226.0

455.0

422.0

Goodwill, Impairment Loss

(2.0)

0.0

(687.0)

0.0

Other Cost and Expense, Operating

35.0

23.0

36.0

25.0

Operating earnings

(112.0)

138.0

(838.0)

198.0

Interest expense, net

66.0

47.0

124.0

79.0

Other (income)/expense, net

^[1]

4.0

(23.0)

17.0

2.0

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total

(182.0)

114.0

(979.0)

117.0

Income tax expense

24.0

33.0

(14.0)

36.0

Net earnings/(loss)

$ (206.0)

$ 81.0

$ (965.0)

$ 81.0

Earnings Per Share, Basic

$ (1.13)

$ 0.45

$ (5.31)

$ 0.45

Earnings Per Share, Diluted

$ (1.13)

$ 0.44

$ (5.31)

$ 0.45

[1]	Other expense, net during the three months ended December 31, 2023 and 2022 primarily includes foreign currency remeasurement losses/gains.

CTLT Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash and cash equivalents	$ 229.0	$ 280.0
Trade receivables, net	843.0	1,002.0
Inventories	775.0	777.0
Prepaid expenses and other	723.0	633.0
Total current assets	2,570.0	2,692.0
Property, plant, and equipment, net	3,777.0	3,682.0
Other assets:
Goodwill	2,351.0	3,039.0
Other intangibles, net	911.0	980.0
Deferred Income Tax Assets, Net	55.0	55.0
Other Assets, Noncurrent	324.0	329.0
Total assets	9,988.0	10,777.0
Current Liabilities:
Debt, Current	46.0	536.0
Accounts payable	407.0	424.0
Other accrued liabilities	583.0	570.0
Total current liabilities	1,036.0	1,530.0
Long-term obligations, less current portion	4,959.0	4,313.0
Pension liability	101.0	100.0
Deferred Income Taxes	50.0	76.0
Other liabilities	155.0	147.0
Total liabilities	$ 6,301.0	$ 6,166.0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Value, Outstanding	$ 2.0	$ 2.0
Preferred Stock, Value, Outstanding	0.0	0.0
Additional paid in capital	4,742.0	4,701.0
Accumulated deficit	(703.0)	262.0
Accumulated other comprehensive income/(loss)	(354.0)	(354.0)
Total shareholders' equity	3,687.0	4,611.0
Total liabilities, redeemable preferred stock, and shareholders’ equity	$ 9,988.0	$ 10,777.0
Common stock, shares issued (shares)	181,000,000	180,000,000

About Catalent Inc

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.

CEO	Mr. Alessandro Maselli
WEBSITE	catalent.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	17800

Catalent Inc Frequently Asked Questions

What is the ticker symbol for Catalent Inc? What does CTLT stand for in stocks?

CTLT is the stock ticker symbol of Catalent Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Catalent Inc (CTLT)?

As of Tue Apr 23 2024, market cap of Catalent Inc is 10.13 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CTLT stock?

You can check CTLT's fair value in chart for subscribers.

What is the fair value of CTLT stock?

You can check CTLT's fair value in chart for subscribers. The fair value of Catalent Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Catalent Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CTLT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Catalent Inc a good stock to buy?

The fair value guage provides a quick view whether CTLT is over valued or under valued. Whether Catalent Inc is cheap or expensive depends on the assumptions which impact Catalent Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CTLT.

What is Catalent Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, CTLT's PE ratio (Price to Earnings) is -9.43 and Price to Sales (PS) ratio is 2.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CTLT PE ratio will change depending on the future growth rate expectations of investors.